0 likes | 23 Views
It is the responsibility of drug manufacturers to alert users and/or prescribing physicians to any risks related to the specific product. Mounjaro stomach paralysis lawsuits are on the boom for the dangerous side effects of this diabetic medication.
E N D
Elementary School Presents Mounjaro Stomach Paralysis Lawsuits: The Rising Tide in 2024
Mounjaro—a once celebrated drug for diabetes now stands at the epicenter of a storm. • The drug which was intended for type 2 diabetes, has found itself under the harsh scrutiny of lawsuits.
What is Mounjaro? • Mounjaro is a synthetic peptide (tirzepatide) that functions as both a dual agonist. • It blocks the glucagon-like peptide 1 (GLP-1) receptor and a gastric inhibitory polypeptide (GIP).
It stimulates both first- and second-phase insulin secretion and lowers glucagon levels. • On May 13, 2022, the FDA approved Mounjaro injection as a medication for type 2 diabetes mellitus.
The first Mounjaro lawsuit was filed in August 2023 by the plaintiff Jaclyn Bjorklund. • She developed severe stomach paralysis after taking Mounjaro.
Another lawsuit was filed by Blake, a 38 year old man who took two doses of Mounjaro for diabetes. • Blake filed a lawsuit alleging that the drug manufacturer failed to warn the users about stomach paralysis.
It is estimated that around 10,000 claims are under the investigation stage. • The defendant argue that gastroparesis is often associated with Type II diabetes not with Mounjaro.
Are you harmed by the adverse effects of Mounjaro? It’s the right time to consult an expert Mounjaro lawsuit lawyer with medical record review support.
For a flawless medical record Contact Phone: +1-404-382-5426 Mail: sales@lezdotechmed.com Web: https://www.lezdotechmed.com/